BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 29233297)

  • 1. PPI inhibitor and stabilizer development in human diseases.
    Bosch J
    Drug Discov Today Technol; 2017 Jun; 24():3-9. PubMed ID: 29233297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging roles of allosteric modulators in the regulation of protein-protein interactions (PPIs): A new paradigm for PPI drug discovery.
    Ni D; Lu S; Zhang J
    Med Res Rev; 2019 Nov; 39(6):2314-2342. PubMed ID: 30957264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small-molecule stabilization of protein-protein interactions: an underestimated concept in drug discovery?
    Thiel P; Kaiser M; Ottmann C
    Angew Chem Int Ed Engl; 2012 Feb; 51(9):2012-8. PubMed ID: 22308055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homo- and Heterodimerization of Proteins in Cell Signaling: Inhibition and Drug Design.
    Singh SS; Jois SD
    Adv Protein Chem Struct Biol; 2018; 111():1-59. PubMed ID: 29459028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Network analysis and in silico prediction of protein-protein interactions with applications in drug discovery.
    Murakami Y; Tripathi LP; Prathipati P; Mizuguchi K
    Curr Opin Struct Biol; 2017 Jun; 44():134-142. PubMed ID: 28364585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stabilization of protein-protein interactions in drug discovery.
    Andrei SA; Sijbesma E; Hann M; Davis J; O'Mahony G; Perry MWD; Karawajczyk A; Eickhoff J; Brunsveld L; Doveston RG; Milroy LG; Ottmann C
    Expert Opin Drug Discov; 2017 Sep; 12(9):925-940. PubMed ID: 28695752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulators of 14-3-3 Protein-Protein Interactions.
    Stevers LM; Sijbesma E; Botta M; MacKintosh C; Obsil T; Landrieu I; Cau Y; Wilson AJ; Karawajczyk A; Eickhoff J; Davis J; Hann M; O'Mahony G; Doveston RG; Brunsveld L; Ottmann C
    J Med Chem; 2018 May; 61(9):3755-3778. PubMed ID: 28968506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hotspot Identification and Drug Design of Protein-Protein Interaction Modulators Using the Fragment Molecular Orbital Method.
    Monteleone S; Fedorov DG; Townsend-Nicholson A; Southey M; Bodkin M; Heifetz A
    J Chem Inf Model; 2022 Aug; 62(16):3784-3799. PubMed ID: 35939049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benchmark Study Based on 2P2I
    Wang Z; Kang Y; Li D; Sun H; Dong X; Yao X; Xu L; Chang S; Li Y; Hou T
    J Phys Chem B; 2018 Mar; 122(9):2544-2555. PubMed ID: 29420886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of Protein-Protein Interactions for the Development of Novel Therapeutics.
    Petta I; Lievens S; Libert C; Tavernier J; De Bosscher K
    Mol Ther; 2016 Apr; 24(4):707-18. PubMed ID: 26675501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantum Molecular Dynamics, Topological, Group Theoretical and Graph Theoretical Studies of Protein-Protein Interactions.
    Balasubramanian K; Gupta SP
    Curr Top Med Chem; 2019; 19(6):426-443. PubMed ID: 30836919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein-protein interaction modulator drug discovery: past efforts and future opportunities using a rich source of low- and high-throughput screening assays.
    Gul S; Hadian K
    Expert Opin Drug Discov; 2014 Dec; 9(12):1393-404. PubMed ID: 25374163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stabilizer-Guided Inhibition of Protein-Protein Interactions.
    Milroy LG; Bartel M; Henen MA; Leysen S; Adriaans JM; Brunsveld L; Landrieu I; Ottmann C
    Angew Chem Int Ed Engl; 2015 Dec; 54(52):15720-4. PubMed ID: 26537010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current Challenges and Opportunities in Designing Protein-Protein Interaction Targeted Drugs.
    Shin WH; Kumazawa K; Imai K; Hirokawa T; Kihara D
    Adv Appl Bioinform Chem; 2020; 13():11-25. PubMed ID: 33209039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breaking the Fourth Wall: Modulating Quaternary Associations for Protein Regulation and Drug Discovery.
    Long MJC; Hnedzko D; Kim BK; Aye Y
    Chembiochem; 2019 May; 20(9):1091-1104. PubMed ID: 30589188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noncellular screening for the discovery of protein-protein interaction modulators.
    Kieffer C; Jourdan JP; Jouanne M; Voisin-Chiret AS
    Drug Discov Today; 2020 Sep; 25(9):1592-1603. PubMed ID: 32682931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using peptides to study protein-protein interactions.
    Benyamini H; Friedler A
    Future Med Chem; 2010 Jun; 2(6):989-1003. PubMed ID: 21426115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of modulators of protein-protein interactions: current approaches and limitations.
    Meireles LM; Mustata G
    Curr Top Med Chem; 2011; 11(3):248-57. PubMed ID: 21320056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stabilization of Protein-Protein Interactions in chemical biology and drug discovery.
    Bier D; Thiel P; Briels J; Ottmann C
    Prog Biophys Mol Biol; 2015 Oct; 119(1):10-9. PubMed ID: 26093250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using yeast as a model to study membrane proteins.
    Petschnigg J; Moe OW; Stagljar I
    Curr Opin Nephrol Hypertens; 2011 Jul; 20(4):425-32. PubMed ID: 21587075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.